Picture of Apyx Medical logo

APYX Apyx Medical News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareSpeculativeSmall CapHigh Flyer

Apyx Medical Corp reports results for the quarter ended in March - Earnings Summary

* Apyx Medical Corp  APYX.OQ  reported a quarterly adjusted
loss
of 17 cents​​ per share for the quarter ended in March. The mean
expectation of three analysts for the quarter was for a loss
of 15 cents per share.
    * Revenue rose 44.6% to $12.49 million from a year ago; 
analysts
expected $11.12 million. 
    * Apyx Medical Corp's reported EPS for the quarter was a
loss
of 17 cents​.
    * The mean earnings estimate of analysts had fallen by
about 2.9%
in the last three months.​ 
    * In the last 30 days there have been no earnings estimate
revisions by analysts covering the company. 
    * Apyx Medical Corp shares had fallen by 52.4% this
quarter and
lost 75.7% so far this year.
    * The company reported a quarterly loss of $5.95 million.
    * Wall Street's median 12-month price target for Apyx
Medical Corp
is $15.00 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 2 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell." 

This summary was machine generated May 12 at 02:07 p.m.  ​All
figures in US dollars unless otherwise stated

Recent news on Apyx Medical

See all news